Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PfSPZ Vaccine DVI in Healthy Adults
NCT02215707Phase 1Completed
- Sponsor
- Sanaria Inc.
- Start
- Jun 2014
- Primary completion
- Apr 2015
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 1, open-label trial of Sanaria PfSPZ Vaccine in malaria (4 arms), sponsored by Sanaria Inc. Primary endpoints: Incidence and type of adverse events and Evidence of vaccine-mediated protection against CHMI. Started Jun 2014; status: completed.
02
Drugs
Sanaria PfSPZ Vaccine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT02215707.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02215707.